NEW YORK – Celent has released a new report titled Research as a Service: Assessing the Implications of MiFID II on Investment Research. The report was written by John Dwyer, a Senior Analyst with Celent’s Securities & Investments practice.
Research Aggregators have emerged offering the buy side access to research via a platform with transparent pricing, usage-analytics, and budgeting tools.
A key driver of the success of these platforms will be the pricing strategy; we explore the implications of a “per report” pricing approach versus a subscription-based Research as a Service approach.
Research as a Service harnesses best-in-class technology to optimize transparency, compliance, and pricing of research. In addition, it also combines digital publishing and alignment of incentives to create a network generating actionable alpha. Smartkarma is pioneering the Research as a Service model across Asian markets. Its recent partnership with Société Générale reflects an important milestone for the investment research industry. Real consensus among the buy and sell side remains elusive – other than an expectation that the regulatory picture is likely to remain mixed.
“The regulatory pulse is likely to quicken through 2017 as evidenced by the FCA’s recent announcements regarding firms failing to meet their expectations in a number of key research related areas including monitoring, pricing, budgeting, and record-keeping,” commented Dwyer.
“The initial focus of the incumbents on the buy side and sell side is likely to be on compliance. However, as new operating procedures are put into place and the research evolves to a P2P approach then greater scrutiny will emerge on commercial implications of how alpha-generating research should be monetized,” he added.
About Celent
Celent is a research and advisory firm dedicated to helping financial institutions formulate comprehensive business and technology strategies. Celent publishes reports identifying trends and best practices in financial services technology and conducts consulting engagements for financial institutions looking to use technology to enhance existing business processes or launch new business strategies. With a team of internationally experienced analysts, Celent is uniquely positioned to offer strategic advice and market insights on a global basis. Celent is a member of the Oliver Wyman Group, which is part of Marsh & McLennan Companies [NYSE: MMC].